Implementation of highly effective therapy for hepatitis C [ 2017 - ]

Research Grant

Researchers: Prof Gregory Dore (Principal investigator)

Brief description Hepatitis C is a major public health issue in Australia, and globally, with escalating liver disease burden. Highly effective interferon-free HCV regimens will be available from 2016 and have the potential to provide one of the greatest advances in clinical medicine in recent decades. Development of implementation strategies for new HCV therapies, particularly for highly marginalised populations including people who inject drugs and prisoners, is crucial to provide broad public health impact.

Funding Amount $569,219.00

Funding Scheme Practitioner Fellowships

Notes Practitioner Fellowship